Deutsch
 
Hilfe Datenschutzhinweis Impressum
  DetailsucheBrowse

Datensatz

 
 
DownloadE-Mail
  Huntington's Disease: from Molecular Basis to Therapeutic Advances.

Krobitsch, S., & Kazantsev, A. G. (2011). Huntington's Disease: from Molecular Basis to Therapeutic Advances. The International Journal of Biochemistry & Cell Biology., 43(1), 20-24. doi:10.1016/j.biocel.2010.10.014 |.

Item is

Basisdaten

einblenden: ausblenden:
Genre: Zeitschriftenartikel
Alternativer Titel : Int. J. Biochem. Cell Biol.

Dateien

einblenden: Dateien
ausblenden: Dateien
:
sdarticle.pdf (beliebiger Volltext), 588KB
 
Datei-Permalink:
-
Name:
sdarticle.pdf
Beschreibung:
-
OA-Status:
Sichtbarkeit:
Eingeschränkt (Max Planck Institute for Molecular Genetics, MBMG; )
MIME-Typ / Prüfsumme:
application/pdf
Technische Metadaten:
Copyright Datum:
-
Copyright Info:
eDoc_access: MPG
Lizenz:
-

Externe Referenzen

einblenden:

Urheber

einblenden:
ausblenden:
 Urheber:
Krobitsch, Sylvia1, Autor           
Kazantsev, Aleksey G.2, Autor
Affiliations:
1Neurodegenerative Disorders (Sylvia Krobitsch), Independent Junior Research Groups (OWL), Max Planck Institute for Molecular Genetics, Max Planck Society, ou_1479661              
2Max Planck Society, ou_persistent13              

Inhalt

einblenden:
ausblenden:
Schlagwörter: Neurodegeneration; Huntington's disease; Huntingtin; Neuroprotection
 Zusammenfassung: Huntington's disease is an autosomal dominant genetic neurodegenerative disorder, which is characterized by progressive motor dysfunction, emotional disturbances, dementia, and weight loss. The disease is caused by pathological CAG-triplet repeat extension(s), encoding polyglutamines, within the gene product, huntingtin. Huntingtin is ubiquitously expressed through the body and is a protein of uncertain molecular function(s). Mutant huntingtin, containing pathologically extended polyglutamines causes the earliest and most dramatic neuropathologic changes in the neostriatum and cerebral cortex. Extended polyglutamines confer structural conformational changes to huntingtin, which gains novel properties, resulting in aberrant interactions with multiple cellular components. The diverse and variable aberrations mediated by mutant huntingtin perturb many cellular functions essential for neuronal homeostasis and underlie pleiotropic mechanisms of Huntington's disease pathogenesis. The only approved drug for Huntington's disease is a symptomatic treatment, tetrabenazine; thus, novel neuroprotective strategies, slowing, blocking and possibly reversing disease progression, are vital for developing effective therapies.

Details

einblenden:
ausblenden:
Sprache(n): eng - English
 Datum: 2011-01-01
 Publikationsstatus: Erschienen
 Seiten: -
 Ort, Verlag, Ausgabe: -
 Inhaltsverzeichnis: -
 Art der Begutachtung: -
 Art des Abschluß: -

Veranstaltung

einblenden:

Entscheidung

einblenden:

Projektinformation

einblenden:

Quelle 1

einblenden:
ausblenden:
Titel: The International Journal of Biochemistry & Cell Biology.
  Alternativer Titel : Int. J. Biochem. Cell Biol.
Genre der Quelle: Zeitschrift
 Urheber:
Affiliations:
Ort, Verlag, Ausgabe: -
Seiten: - Band / Heft: 43 (1) Artikelnummer: - Start- / Endseite: 20 - 24 Identifikator: ISSN: 1357-2725